Using serological measures to monitor changes in malaria transmission in Vanuatu

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Cook, Jackie ^a   Reid, Heidi ^b   Iavro, Jennifer ^c   Kuwahata, Melissa ^d   Taleo, George ^c   Clements, Archie ^b   McCarthy, James ^b,d   Vallely, Andrew ^b   Drakeley, Chris ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Ministry of Health   (Vanuatu)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; PROTOZOON ANTIBODY; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CATALYST; CHILD; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL ETHICS; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRESCHOOL CHILD; SCHOOL CHILD; SEROCONVERSION; SEROEPIDEMIOLOGY; SEROPREVALENCE; VANUATU; BLOOD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; GENETICS; IMMUNOLOGY; MALARIA FALCIPARUM; METABOLISM; MIDDLE AGED; NEWBORN; PLASMODIUM VIVAX MALARIA; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREVALENCE; PROTOZOAN PROTEINS; SEROEPIDEMIOLOGIC STUDIES; VANUATU; YOUNG ADULT;

EID: 77953519634     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-169     Document Type: Article

References (46)

1. RGA Feachem AA Phillips GA Targett, Shrinking the Malaria Map: A prospectus on Malaria Elimination The Global Health Group 2009
2. Identification of hot spots of malaria transmission for targeted malaria control. T Bousema C Drakeley S Gesase R Hashim S Magesa F Mosha S Otieno I Carneiro J Cox E Msuya I Kleinschmidt C Maxwell B Greenwood E Riley R Sauerwein D Chandramohan R Gosling, J Infect Dis 2010 201 1764 1774 10.1086/652456 20415536
3. Malaria eradication on islands. A Kaneko G Taleo M Kalkoa S Yamar T Kobayakawa A Bjorkman, Lancet 2000 356 1560 1564 10.1016/S0140-6736(00)03127-5 11075770
4. Malaria in Sao Tome and principe: on the brink of elimination after three years of effective antimalarial measures. HD Teklehaimanot A Teklehaimanot A Kiszewski HS Rampao JD Sachs, Am J Trop Med Hyg 2009 80 133 140 19141851
5. Seroepidemiological evidence of eradication of malaria from Mauritius. LJ Bruce-Chwatt CC Draper P Konfortion, Lancet 1973 2 547 551 10.1016/S0140- 6736(73)92361-1 4125305
6. Endemicity response timelines for Plasmodium falciparum elimination. DL Smith SI Hay, Malar J 2009 8 87 10.1186/1475-2875-8-87 19405974
7. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. LA Kelly-Hope FE McKenzie, Malar J 2009 8 19 10.1186/1475-2875-8-19 19166589
8. Moderate transmission but high prevalence of malaria in Madagascar. V Robert G Le Goff L Andrianaivolambo FM Randimby O Domarle M Randrianarivelojosia V Raharimanga A Raveloson C Ravaonjanahary F Ariey, Int J Parasitol 2006 36 1273 1281 10.1016/j.ijpara.2006.06.005 16842796 (Pubitemid 44353483)
9. Relationship between entomological inoculation rate, Plasmodium falciparum prevalence rate, and incidence of malaria attack in rural Gabon. N Elissa F Migot-Nabias A Luty A Renaut F Toure M Vaillant M Lawoko P Yangari J Mayombo F Lekoulou P Tshipamba R Moukagni P Millet P Deloron, Acta Trop 2003 85 355 361 10.1016/S0001-706X(02)00266-8 12659973
10. Serology: a robust indicator of malaria transmission intensity? P Corran P Coleman E Riley C Drakeley, Trends Parasitol 2007 23 575 582 10.1016/j.pt.2007.08.023 17988945
11. Serological malaria surveys in Nigeria. A Voller LJ Bruce-Chwatt, Bull World Health Organ 1968 39 883 897 4893493
12. Changing patterns in the humoral immune response to malaria before, during, and after the application of control measures: a longitudinal study in the West African savanna. R Cornille-Brogger HM Mathews J Storey TS Ashkar S Brogger L Molineaux, Bull World Health Organ 1978 56 579 600 365386
13. A longitudinal study of Plasmodium falciparum malaria in the West African savannah using the ELISA technique. A Voller R Cornille-Brogger J Storey L Molineaux, Bull World Health Organ 1980 58 429 438 6998590
14. Malaria in the Pare area of Tanzania. IV. Malaria in the human population 11 years after the suspension of residual insecticide spraying, with special reference to the serological findings. CC Draper JL Lelijveld YG Matola GB White, Trans R Soc Trop Med Hyg 1972 66 905 912 10.1016/0035-9203(72)90126-5 4569251
15. Etude sero-epidemiologique longitudinale sur la paludisme en Tunisie. P Ambroise-Thomas WH Wernsdorfer B Grab J Cullen P Bertagna, Bull Organ Mond Sante 1976 54 355 367
16. Sero-epidemiological surveillance of disappearing malaria in Greece. LJ Bruce-Chwatt CC Draper D Avramidis O Kazandzoglou, J Trop Med Hyg 1975 78 194 200 772232
17. Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. C Drakeley J Cook, Adv Parasitol 2009 69 299 352 full-text 19622411
18. Estimating medium and long term trends in malaria transmission using serological markers of malaria exposure. C Drakeley P Corran PG Coleman JE Tongren S McDonald I Carneiro R Malima JPA Lusingu A Manjurano WM Nkya MM Lemnge J Cox H Reyburn EM Riley, Proc Natl Acad Sci USA 2005 102 5108 5113 10.1073/pnas.0408725102 15792998
19. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. PH Corran J Cook C Lynch H Leendertse A Manjurano J Griffin J Cox T Abeku T Bousema AC Ghani C Drakeley EM Riley, Malar J 2008 7 195 10.1186/1475-2875-7-195 18826573
20. Rapid assessment of malaria transmission using age-specific sero-conversion rates. L Stewart R Gosling J Griffin S Gesase J Campo R Hashim P Masika J Mosha T Bousema S Shekalaghe J Cook P Corran A Ghani EM Riley C Drakeley, PLoS One 2009 4 6083 10.1371/journal.pone.0006083 19562032
21. Immunophoretic rapid diagnostic tests as a source of immunoglobulins for estimating malaria sero-prevalence and transmission intensity. GS Williams C Mweya L Stewart G Mtove H Reyburn J Cook PH Corran EM Riley CJ Drakeley, Malar J 2009 8 168 10.1186/1475-2875-8-168 19624812
22. Baseline spatial distribution of malaria prior to an elimination program in Vanuatu. H Reid A Vallely G Taleo AJ Tatem G Kelly I Riley I Harris H Iata S Yama A Clements, Malar J 2010
23. Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. JA Atkinson L Fitzgerald H Toaliu G Taleo A Tynan M Whittaker I Riley A Vallely, Malar J 2010 9 93 10.1186/1475-2875-9-93 20380748
24. Malaria transmission pattern resilience to climatic variability is mediated by insecticide-treated nets. LF Chaves A Kaneko G Taleo M Pascual ML Wilson, Malar J 2008 7 100 10.1186/1475-2875-7-100 18518983
25. An innovative database for epidemiological field studies of neglected tropical diseases. DJ Gray SJ Forsyth RS Li DP McManus Y Li H Chen F Zheng GM Williams, PLoS Negl Trop Dis 2009 3 413 10.1371/journal.pntd.0000413 19478833
26. Logistic discrimination of mixtures of M. tuberculosis and non-specific tuberculin reactions. NJ Nagelkerke MW Borgdorff SJ Kim, Stat Med 2001 20 1113 1124 10.1002/sim.745 11276040
27. Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture models. P Hardelid D Williams C Dezateux PA Tookey CS Peckham WD Cubitt M Cortina-Borja, Epidemiol Infect 2008 1 9
28. Measles serological survey in the Italian population: Interpretation of results using mixture model. MC Rota M Massari G Gabutti M Guido A De Donno ML Atti, Vaccine 2008 26 4403 4409 10.1016/j.vaccine.2008.05.094 18585420
29. Secretariat of the Pacific Community: Oceania Population Data Sheet. SPC, 2000
30. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. FH Osier G Fegan SD Polley L Murungi F Verra KK Tetteh B Lowe T Mwangi PC Bull AW Thomas DR Cavanagh JS McBride DE Lanar MJ Mackinnon DJ Conway K Marsh, Infect Immun 2008 76 2240 2248 10.1128/IAI.01585-07 18316390
31. Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. OJ Akpogheneta NO Duah KK Tetteh S Dunyo DE Lanar M Pinder DJ Conway, Infect Immun 2008 76 1748 1755 10.1128/IAI.01333-07 18212081
32. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. SM Kinyanjui DJ Conway DE Lanar K Marsh, Malar J 2007 6 82 10.1186/1475-2875-6-82 17598897
33. Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. J Wipasa C Suphavilai LC Okell J Cook PH Corran K Thaikla W Liewsaree EM Riley JC Hafalla, PLoS Pathog 2010 6 1000770 10.1371/journal.ppat.1000770 20174609
34. Vivax malaria: neglected and not benign. RN Price E Tjitra CA Guerra S Yeung NJ White NM Anstey, Am J Trop Med Hyg 2007 77 79 87 18165478
35. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. K Maitland TN Williams S Bennett CI Newbold TE Peto J Viji R Timothy JB Clegg DJ Weatherall DK Bowden, Trans R Soc Trop Med Hyg 1996 90 614 620 10.1016/S0035-9203(96)90406-X 9015495
36. Differential patterns of infection and disease with P. falciparum and P. vivax in Young Papua New Guinean children. E Lin B Kiniboro L Gray S Dobbie L Robinson A Laumaea S Schopflin D Stanisic I Betuela M Blood-Zikursh P Siba I Felger L Schofield P Zimmerman I Mueller, PLoS One 2010 5 9047 10.1371/journal.pone.0009047 20140220
37. Are insecticide-treated bednets more protective against Plasmodium falciparum than Plasmodium vivax-infected mosquitoes? MJ Bockarie H Dagoro, Malar J 2006 5 15 10.1186/1475-2875-5-15 16504027
38. The neglected burden of Plasmodium vivax malaria. K Mendis BJ Sina P Marchesini R Carter, Am J Trop Med Hyg 2001 64 97 106 11425182
39. Spatiotemporal patterns of malaria incidence in northern Thailand. DZ Childs IM Cattadori W Suwonkerd S Prajakwong M Boots, Trans R Soc Trop Med Hyg 2006 100 623 631 10.1016/j.trstmh.2005.09.011 16406037
40. Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control. M da Silva-Nunes CT Codeco RS Malafronte NS da Silva C Juncansen PT Muniz MU Ferreira, Am J Trop Med Hyg 2008 79 624 635 18840755
41. Malaria imported into Reunion Island: is there a risk of re-emergence of the disease? E D'Ortenzio D Sissoko JS Dehecq P Renault L Filleul, Trans R Soc Trop Med Hyg 2009 19914673
42. Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum. CW Naus FM Jones MZ Satti S Joseph EM Riley G Kimani JK Mwatha CH Kariuki JH Ouma NB Kabatereine BJ Vennervald DW Dunne, J Infect Dis 2003 187 1272 1282 10.1086/368361 12696007
43. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium. F Mutapi C Roussilhon T Mduluza P Druilhe, Mem Inst Oswaldo Cruz 2007 102 405 409 10.1590/S0074-02762007005000046 17568947
44. Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence. C Abramo CJ Fontes AU Krettli, Am J Trop Med Hyg 1995 53 202 205 7677225
45. The Toxoplasma homolog of Plasmodium apical membrane antigen-1 (AMA-1) is a microneme protein secreted in response to elevated intracellular calcium levels. CG Donahue VB Carruthers SD Gilk GE Ward, Mol Biochem Parasitol 2000 111 15 30 10.1016/S0166-6851(00)00289-9 11087913
46. Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. FR Gaffar AP Yatsuda FF Franssen E de Vries, Infect Immun 2004 72 2947 2955 10.1128/IAI.72.5.2947-2955. 2004 15102807